Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Happy New Year!

now that's what I'm talking about!

Thanks for posting that.

On top of the negative earnings that RMBS posts, look at the debt they have too.

And they lowered their revenue guidance recently to $40 Million Annually.

Yet they trade at $17 dollars a share. Why? Because they are a known commodity at this point in time. They can project revenues.

JT said that he does not want to fund someone else's science project.

He wants to be able to say to the investment community:

"We shipped 50 widgets this month and we'll be shipping 100 next month"

I hope we become a Dover type co. buying companies generating a nice profit off the bat.

We shall see.........right ron?

Deb

Share
New Message
Please login to post a reply